Recent advancements in liquid biopsies have demonstrated the potential of cfDNA as a universal, minimally invasive sample type in cancer prognosis, diagnosis, and prenatal testing 1. In parallel, the ...
A key obstacle in isolating cfDNA is the intricate, labor-intensive manual process required by existing protocols to extract it for downstream processing. This article introduces a unique automated ...
Proximity ligation assay (PLA) to identify HER2-negative breast carcinomas responding in HER-3 targeting agents. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...
As cost of sequencing continues to drop, the throughput and complexity of NGS assays have risen precipitously. At the same time, the types of samples being used for these assays have expanded as ...
Scientists increasingly appreciate the importance of molecular testing for early cancer detection. 1 Cell free DNA (cfDNA) analysis eliminates the need for invasive tissue biopsies for detection, ...
New England Biolabs has released the Monarch ® Mag Cell-free DNA (cfDNA) Extraction Kit, a bead-based method designed for scalable and reproducible isolation of low abundance cfDNA from plasma, serum, ...
The much-touted arrival of "precision medicine" promises tailored technologies that help individuals and may also reduce health care costs. New research shows how pregnancy screening can meet both of ...
Yourgene Health plc (“Yourgene”), a leading international molecular diagnostics group, today launched the Yourgene ® MagBench ™ Automated DNA Extraction Instrument and Kit. MagBench solution is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results